Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antibody COVID-19”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT07085611
What this trial is testing

Neutralizing Power of Serum Antibodies - 2

Who this might be right for
COVID-19SARS-CoV-2 ViraemiaMonkey Pox+3 more
Centre Hospitalier Régional d'Orléans 30
Early research (Phase 1)Study completedNCT05923424
What this trial is testing

A Trial to Learn if Different Doses of REGN17092 Are Safe in Healthy Adults

Who this might be right for
Healthy Volunteers
Regeneron Pharmaceuticals 40
Not applicableLooking for participantsNCT05242159
What this trial is testing

Prevalence and Clinical Significance of Anti-annexin A2 Antibodies in COVID-19 Infection

Who this might be right for
COVID-19
Centre Hospitalier Universitaire, Amiens 300
Not applicableUnknownNCT04429620
What this trial is testing

Prospective Assay for SARS-CoV-2 (COVID-19) Antibody Detection Indirectly by Immunofluorescence: SARS-CoV2 IIF Method

Who this might be right for
Sars-CoV2
Szeged University 100
Not applicableStudy completedNCT04347408
What this trial is testing

Seroprevalence of SARS-Cov-2 Antibodies in Children

Who this might be right for
COVIDCorona Virus InfectionMultisystem Inflammatory Syndrome in Children
Queen's University, Belfast 1,100
Early research (Phase 1)UnknownNCT06050460
What this trial is testing

SA55 Injection: a Potential Therapy for the Prevention and Treatment of COVID-19

Who this might be right for
COVID-19
Sinovac Life Sciences Co., Ltd. 40
Not applicableStudy completedNCT04483908
What this trial is testing

COVID-19 in Baselland: Investigation and Validation of Serological Diagnostic Assays and Epidemiological Study of Sars-CoV-2 Specific Antibody Responses

Who this might be right for
COVID-19 Infection
University Hospital, Basel, Switzerland 477
Not applicableStudy completedNCT04845880
What this trial is testing

SARS Cov_2 Incidence of Healthy Health Workers

Who this might be right for
SARS COV-2 IgG Levels on Health Workers
Baskent University 182
Not applicableStudy completedNCT04448717
What this trial is testing

COVID-19: Longitudinal Study of Seroprevalence of SARS-CoV-2 Antibodies and Development of Immunity in School Children

Who this might be right for
SARS-CoV 2COVID-19
University of Zurich 4,250
Not applicableStudy completedNCT04961385
What this trial is testing

Immunogenicity of the ChAdox1 n CoV-19 Vaccine With 12-dose Vial

Who this might be right for
Covid19VaccineImmunogenicity
Bangkok Metropolitan Administration Medical College and Vajira Hospital 60
Testing effectiveness (Phase 2)Study completedNCT05028374
What this trial is testing

COVID-19 VAX Booster Dosing in Patients With Hematologic Malignancies

Who this might be right for
Multiple MyelomaAL AmyloidosisChronic Lymphocytic Leukemia
Barbara Ann Karmanos Cancer Institute 119
Not applicableUnknownNCT04444310
What this trial is testing

Antibody Responses in Contacts of COVID-19 Patients

Who this might be right for
COVID-19
Assiut University 100
Large-scale testing (Phase 3)Ended earlyNCT04847141
What this trial is testing

Evaluate the Safety and Efficacy of C19-IG 20% in SARS-CoV-2 Infected Asymptomatic Ambulatory Outpatients

Who this might be right for
COVID-19Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection
Grifols Therapeutics LLC 465
Testing effectiveness (Phase 2)UnknownNCT06159283
What this trial is testing

Intravenous Immunoglobulin Replacement Therapy for Persistent COVID-19 in Patients With B-cell Impairment

Who this might be right for
COVID-19
Jaehoon Ko 58
Not applicableStudy completedNCT04581889
What this trial is testing

Prevalence of Antibodies Against SARS-CoV-2 Virus That Causes COVID-19 in Tübingen Children

Who this might be right for
Severe Acute Respiratory Syndrome
University Hospital Tuebingen 2,380
Not applicableStudy completedNCT04542980
What this trial is testing

Qualitative Evaluation of Tear Fluid and Blood for Auto Antibodies Produced in Response to COVID-19

Who this might be right for
SARS-CoV 2 InfectionCovid19
Namida Lab 44
Not applicableStudy completedNCT04596098
What this trial is testing

Immune Responses to COVID-19; Isolation of Neutralizing Antibodies for Therapeutics and Vaccine.

Who this might be right for
SARS-CoV 2
University Hospital, Grenoble 55
Not applicableNot Yet RecruitingNCT06992401
What this trial is testing

Observational Study of Intranasal IVIG in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Patients Undergoing Medical Tourism

Who this might be right for
Post-Acute Sequelae of SARS-CoV-2 InfectionLong COVIDLong COVID Fatigue+3 more
Tamara C Tamas 50
Not applicableStudy completedNCT04918940
What this trial is testing

Efficacy of COVID-19 Vaccination in Patientstreated With Anti-CD20 for Follicular Lymphoma or Mantle Cell Lymphoma

Who this might be right for
Follicular LymphomaMantle Cell Lymphoma
Centre Henri Becquerel 20
Not applicableStudy completedNCT05074706
What this trial is testing

Evaluation of the Immune Response to Sars-Covid-19 Vaccines in Haematological Patients: Prospective Single Center Study

Who this might be right for
Hematologic Diseases
University of Milano Bicocca 700
Next Page